Numerous advantages offered by aptamers over well-established antibodies have made them a widely studied biomedical class among scientists worldwide. They can be directly tested for in-vivo techniques and completely bypass in-vitro testing process, saving both time and cost of research and development. Furthermore, factors such as high thermal stability and cost-efficiency are likely to boost their usage in future.
What are ‘Aptamers’?
Aptamers are peptide molecules or oligonucleotides that bind to target nucleic acid molecules, lipid, or protein with strong specificity. These molecules are created rapidly and utilized in the characterization of proteins, specific detection, and inhibition. They can be utilized as functional proteomic levels, detection reagents, and pharmaceutical leads with small molecules, antibodies, and other aptamers.
Utilization of Aptamers in Development of Breakthrough Assays
Globally, biotechnology and pharmaceutical organizations are acknowledging the benefits of aptamers. Therefore, they are utilizing these molecules in their offerings to develop breakthrough drugs and treatments. To put this in perspective, in August 2017, Bellbrook Labs unveiled its latest drug discovery tool, AptaFluor SAH Methyltransferase Assay, which is a homogeneous assay using aptamers for high throughput screening (HTS). This first-of-its kind assay will pave the way for highly reliable drugs targeting epigenetic pathways that promote debilitating diseases such as cancer. Increasing utilization of aptamers is, therefore, expected to widen their scope of applications.
Market Insights
The global aptamers market is estimated to gain significant impetus with growing investments in research and development activities by pharmaceutical and biotechnology companies. Advancements in technologies pertaining to aptamer development can also supplement market growth, finds Grand View Research Inc. Moreover, rising awareness regarding merits of these molecules, especially in developing countries, can work in favor of the market.
On the other hand, lack of proper regulatory guidelines on molecule development is making way for ethical issues, which in turn is likely to keep the market from realizing its utmost potential.
Some of the key players in the market are Base Pair Biotechnologies Inc.; Aptagen LLC; Aptamer Sciences Inc.; Aptamer Group; and Ophthotech Corporation.
In-Depth research report on Aptamers Market:
https://www.grandviewresearch.com/industry-analysis/aptamers-industry
No comments:
Post a Comment